Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Get Free Report) have received an average rating of “Hold” from the fifteen ratings firms that are currently covering the company, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell rating, five have given a hold rating, seven have given a buy rating and one has given a strong buy rating to the company. The average 12-month price target among analysts that have issued a report on the stock in the last year is $29.8462.
ACHC has been the subject of several recent research reports. Royal Bank Of Canada upped their price target on shares of Acadia Healthcare from $28.00 to $31.00 and gave the stock an “outperform” rating in a research report on Monday, May 4th. Raymond James Financial raised shares of Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 target price for the company in a research note on Monday, May 4th. Guggenheim upped their target price on shares of Acadia Healthcare from $38.00 to $39.00 and gave the stock a “buy” rating in a research report on Thursday, July 30th. UBS Group raised their price target on shares of Acadia Healthcare from $31.00 to $39.00 and gave the company a “buy” rating in a research note on Thursday, July 9th. Finally, Weiss Ratings reaffirmed a “sell (d)” rating on shares of Acadia Healthcare in a report on Friday, June 12th.
Check Out Our Latest Research Report on ACHC
Acadia Healthcare Price Performance
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last issued its earnings results on Tuesday, July 28th. The company reported $0.38 EPS for the quarter, beating analysts’ consensus estimates of $0.35 by $0.03. Acadia Healthcare had a positive return on equity of 6.19% and a negative net margin of 33.44%.The company had revenue of $865.84 million during the quarter, compared to the consensus estimate of $844.19 million. During the same period in the previous year, the firm posted $0.83 earnings per share. Acadia Healthcare’s quarterly revenue was down .4% compared to the same quarter last year. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. As a group, sell-side analysts expect that Acadia Healthcare will post 1.54 earnings per share for the current year.
Institutional Trading of Acadia Healthcare
Several hedge funds have recently added to or reduced their stakes in the business. EverSource Wealth Advisors LLC boosted its stake in Acadia Healthcare by 54.8% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock valued at $32,000 after purchasing an additional 497 shares in the last quarter. Federated Hermes Inc. increased its position in shares of Acadia Healthcare by 1.5% during the 4th quarter. Federated Hermes Inc. now owns 43,913 shares of the company’s stock valued at $623,000 after purchasing an additional 668 shares during the period. Price T Rowe Associates Inc. MD raised its stake in shares of Acadia Healthcare by 0.9% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 74,907 shares of the company’s stock worth $1,063,000 after buying an additional 696 shares in the last quarter. Treasurer of the State of North Carolina lifted its holdings in shares of Acadia Healthcare by 2.1% in the second quarter. Treasurer of the State of North Carolina now owns 42,502 shares of the company’s stock valued at $964,000 after buying an additional 867 shares during the period. Finally, Public Employees Retirement System of Ohio boosted its stake in Acadia Healthcare by 2.8% during the third quarter. Public Employees Retirement System of Ohio now owns 31,335 shares of the company’s stock valued at $776,000 after buying an additional 867 shares in the last quarter.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.
Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.
Featured Articles
- Five stocks we like better than Acadia Healthcare
- VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
- 3 Closed-End Funds to Maximize Dividend Payments
- Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy?
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
